It is not possible to perform a magnetic resonance imaging in all patients and as a result echocardiography is not only done at screening but also during the follow up. The imaging technologies made a great progress in the last few years and enable a better assessment of the haemodynamic parameters in our days.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
age \>17
pulmonary arterial hypertension WHO group I who are going to start a therapy with prostanoid
written informed consent
Prostanoid naive
no change of the pulmonary arterial hypertension therapy within 3 weeks of inclusion into the study
You may not be if
pregnancy and lactation period
Women of childbearing potential who do not use an effective and secure method for birth control
severe chronic kidney insufficiency (glomerular filtration rate \<30), which will remain for more than 3 months
liver insufficiency Child C
life expectancy shorter than the course of the study (for example because of a malignant disease)
Clareo Health | Imaging Control Study, 3D Echo, MR and RHC.
